AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
GB9902689D0
(en)
*
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
DE19921693A1
(de)
*
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US7214687B2
(en)
|
1999-07-14 |
2007-05-08 |
Almirall Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
CO5270018A1
(es)
*
|
1999-12-11 |
2003-04-30 |
Glaxo Group Ltd |
Distribuidor de medicamento
|
US6651655B1
(en)
*
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
EA005179B1
(ru)
|
2000-05-22 |
2004-12-30 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Стабильные фармацевтические препараты в виде растворов для дозированных ингаляторов под давлением
|
US20060257324A1
(en)
*
|
2000-05-22 |
2006-11-16 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical solution formulations for pressurised metered dose inhalers
|
FR2812545B1
(fr)
*
|
2000-08-03 |
2003-03-28 |
Air Liquide Sante Int |
Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
|
US20040081627A1
(en)
*
|
2000-10-09 |
2004-04-29 |
Jinks Phillip A |
Medicinal aerosol formulations
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
RS50218B
(sr)
*
|
2000-10-12 |
2009-07-15 |
Boehringer Ingelheim Pharma Gmbh. & Co.Kg., |
Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje leka
|
HUP0301377A3
(en)
*
|
2000-10-31 |
2005-12-28 |
Boehringer Ingelheim Pharma |
Combination pharmaceutical composition in form of inhalative solution containing a tiotropium salt
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
US6620438B2
(en)
*
|
2001-03-08 |
2003-09-16 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
|
US20020137764A1
(en)
|
2000-10-31 |
2002-09-26 |
Karin Drechsel |
Inhalable formulation of a solution containing a tiotropium salt
|
US20100310477A1
(en)
*
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
DE10111843A1
(de)
*
|
2001-03-13 |
2002-09-19 |
Boehringer Ingelheim Pharma |
Verbindungen zur Behandlung von inflammatorischen Erkrankungen
|
PL207377B1
(pl)
*
|
2001-03-30 |
2010-12-31 |
Jagotec Ag |
Medyczny preparat aerozolowy, sposób wytwarzania medycznego preparatu aerozolowego oraz zastosowanie soli kwasów karboksylowych jako środków pomocniczych w tym preparacie
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
US20030013675A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Boehringer Ingelheim Pharma Kg |
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
|
US6472563B1
(en)
*
|
2001-11-09 |
2002-10-29 |
Sepracor Inc. |
Formoterol tartrate process and polymorph
|
US6858615B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
NZ535018A
(en)
*
|
2002-03-01 |
2007-02-23 |
Chiesi Farmaceutici S |
Pharmaceutical aerosol formulation containing formoterol, and its method of production
|
DE10212264A1
(de)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
DE10214264A1
(de)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen eines Anhydrats
|
US7311894B2
(en)
|
2002-03-28 |
2007-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations containing an anticholinergic
|
US7244415B2
(en)
|
2002-03-28 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations of an anhydrate
|
DE10214263A1
(de)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
|
GB0207899D0
(en)
*
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and cielesonide aerosol formulations
|
GB0207906D0
(en)
*
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and mometasone aerosol formulations
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
KR20050045946A
(ko)
|
2002-06-25 |
2005-05-17 |
애크럭스 디디에스 피티와이 리미티드 |
비정질 약학적 조성물을 이용한 경피전달속도의 제어
|
WO2004052835A1
(en)
*
|
2002-12-10 |
2004-06-24 |
Sepracor Inc. |
Levalbuterol salt
|
WO2004052374A1
(en)
*
|
2002-12-12 |
2004-06-24 |
Altana Pharma Ag |
Combination medicament
|
US20050058606A1
(en)
*
|
2002-12-16 |
2005-03-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing HFC solution formulations
|
US20040152720A1
(en)
*
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
CN1292748C
(zh)
*
|
2003-03-05 |
2007-01-03 |
南昌弘益科技有限公司 |
噻托溴铵吸入粉雾剂及其制备工艺
|
AU2004224367B2
(en)
*
|
2003-03-20 |
2009-10-08 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
|
CA2525943A1
(en)
*
|
2003-05-22 |
2004-12-02 |
Altana Pharma Ag |
Salmeterol and ciclesonide combination
|
GB0312148D0
(en)
*
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
EP1635845A1
(en)
|
2003-06-13 |
2006-03-22 |
ALTANA Pharma AG |
Formoterol and ciclesonide combination
|
GB0315889D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
WO2005013963A1
(en)
*
|
2003-08-06 |
2005-02-17 |
Galephar M/F |
Advantageous combinations for inhalation of nacystelyn and bronchodilators
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
DK1670482T4
(da)
*
|
2003-09-16 |
2022-08-22 |
Covis Pharma B V |
Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
|
CA2576410A1
(en)
*
|
2003-09-18 |
2006-03-31 |
Norton Healthcare Ltd. |
Particles
|
GB0323685D0
(en)
*
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
GB0323684D0
(en)
*
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
NZ548302A
(en)
*
|
2004-02-06 |
2010-04-30 |
Meda Pharma Gmbh & Co Kg |
Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
|
ATE541570T1
(de)
*
|
2004-02-06 |
2012-02-15 |
Meda Pharma Gmbh & Co Kg |
Kombination von anticholinergika und hemmern von phosphodiesterase typ 4 zur behandlung von atemwegserkrankungen
|
CN100569235C
(zh)
*
|
2004-02-06 |
2009-12-16 |
Meda制药有限及两合公司 |
用于哮喘和copd长期治疗的抗胆碱能药和糖皮质激素的组合
|
JP2007524698A
(ja)
*
|
2004-02-27 |
2007-08-30 |
アルタナ ファルマ アクチエンゲゼルシャフト |
シクレソニドとグリコピロニウムとの組合せ物
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
CA2563556C
(en)
*
|
2004-04-20 |
2013-01-29 |
Altana Pharma Ag |
Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
|
PT3520779T
(pt)
*
|
2004-04-23 |
2022-03-22 |
Cydex Pharmaceuticals Inc |
Formulação de dpi contendo éter sulfoalquílicociclodextrina
|
US20050238632A1
(en)
*
|
2004-04-23 |
2005-10-27 |
Alburty David S |
Propellant formulations
|
AU2013201437B2
(en)
*
|
2004-04-23 |
2015-09-03 |
Cydex Pharmaceuticals, Inc |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
ITRM20040268A1
(it)
*
|
2004-05-31 |
2004-08-31 |
Italchimici S P A |
Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
|
ES2391563T5
(es)
*
|
2004-07-02 |
2022-10-26 |
Boehringer Ingelheim Int |
Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor
|
JP3955868B2
(ja)
*
|
2004-12-27 |
2007-08-08 |
株式会社キングジム |
書類等の綴じ具
|
WO2006069998A2
(de)
|
2004-12-27 |
2006-07-06 |
Beiersdorf Ag |
Glycopyrrolat in kosmetischen zubereitungen
|
DE102005029390A1
(de)
*
|
2005-06-23 |
2007-01-04 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Glycopyrroniumbromid und Polyolen
|
GB0501956D0
(en)
*
|
2005-01-31 |
2005-03-09 |
Arrow Internat |
Nebulizer formulation
|
AU2006224842B2
(en)
*
|
2005-03-16 |
2011-09-29 |
Meda Pharma Gmbh & Co Kg |
The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
|
CA2607391A1
(en)
*
|
2005-04-23 |
2006-11-02 |
Boehringer Ingelheim International Gmbh |
Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent
|
US20060239935A1
(en)
*
|
2005-04-23 |
2006-10-26 |
Boehringer Ingelheim International Gmbh |
Compositions for inhalation
|
ES2393794T3
(es)
|
2005-05-02 |
2012-12-28 |
Boehringer Ingelheim International Gmbh |
Nuevas formas cristalinas de bromuro de tiotropio
|
ES2607454T3
(es)
*
|
2005-06-03 |
2017-03-31 |
Acrux Dds Pty Ltd |
Método y composición para el suministro transdérmico de testosterona
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
AU2012200449B2
(en)
*
|
2005-12-21 |
2013-07-25 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
DE602006008665D1
(de)
|
2005-12-21 |
2009-10-01 |
Meda Pharma Gmbh & Co Kg |
Kombination von r,r-glycopyrrolat, rolipram und budesonid zur behandlung von entzündungskrankheiten
|
DE102006017320A1
(de)
*
|
2006-04-11 |
2007-10-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
|
ES2298049B1
(es)
*
|
2006-07-21 |
2009-10-20 |
Laboratorios Almirall S.A. |
Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
|
BRPI0720248A2
(pt)
*
|
2006-12-07 |
2013-12-31 |
Lilly Co Eli |
Artigo de fabricação de prasugrel
|
DE102007002121B4
(de)
*
|
2007-01-10 |
2008-12-11 |
Dräger, Karl-Heinz |
Verwendung eines Flüssiggasgemisches als nichtbrennbares Treibgas zum Feinstverteilen eines Reiz- oder Kampfstoffes
|
CA2608561A1
(en)
*
|
2007-10-29 |
2009-04-29 |
Carl Paluszkiewicz |
Motorcycle wind deflector accessory support
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100598A1
(en)
*
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
LT2435023T
(lt)
|
2009-05-29 |
2016-09-26 |
Pearl Therapeutics, Inc. |
Kompozicijos, skirtos ilgai veikiančių muskarininių antagonistų ir ilgai veikiančių beta-2-adrenerginio receptoriaus agonistų pristatymui į plaučius, ir susiję būdai bei sistemos
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
TR200907237A2
(tr)
|
2009-09-23 |
2011-04-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum kuru toz kombinasyonu
|
GB0918149D0
(en)
*
|
2009-10-16 |
2009-12-02 |
Jagotec Ag |
Improved medicinal aerosol formulation
|
TR200907914A2
(tr)
*
|
2009-10-20 |
2011-05-23 |
Bi̇lgi̇ç Mahmut |
Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
GEP20166479B
(en)
|
2009-12-23 |
2016-05-25 |
Chiesi Farma Spa |
Aerosol formulation for copd
|
TWI495468B
(zh)
|
2009-12-23 |
2015-08-11 |
Chiesi Farma Spa |
治療慢性阻塞性肺病(copd)之醫藥組成物
|
ES2468835T3
(es)
*
|
2009-12-23 |
2014-06-17 |
Chiesi Farmaceutici S.P.A. |
Terapia combinada para EPOC
|
TR200909791A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
TR200909792A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
|
TR200909790A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, formoterol ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
|
TR200909793A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, mometazon ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
|
TR200909789A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, budesonid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
|
US8834931B2
(en)
|
2009-12-25 |
2014-09-16 |
Mahmut Bilgic |
Dry powder formulation containing tiotropium for inhalation
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
GB201108039D0
(en)
|
2011-05-13 |
2011-06-29 |
Mexichem Amanco Holding Sa |
Compositions
|
JP2014519519A
(ja)
|
2011-06-15 |
2014-08-14 |
タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規3,4,4a,10b−テトラヒドロ−1H−チオピラノ[4,3−c]イソキノリン化合物
|
KR20140037195A
(ko)
|
2011-06-17 |
2014-03-26 |
다케다 게엠베하 |
신규 프탈라지논-피롤로피리미딘카복스아미드 유도체
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
GB201117619D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201117621D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
EP3150585A1
(en)
|
2012-12-17 |
2017-04-05 |
Parion Sciences, Inc. |
Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
|
KR20150095870A
(ko)
|
2012-12-17 |
2015-08-21 |
패리온 사이언스 인코퍼레이티드 |
3,5-디아미노-6-클로로-n-(n-(4-페닐부틸)카르밤이미도일)피라진-2-카르복스아미드 화합물
|
WO2014113638A1
(en)
*
|
2013-01-17 |
2014-07-24 |
Aer Devices, Inc. |
Multi-use albuterol maintenance therapy formulations and devices therefor
|
WO2014144894A1
(en)
|
2013-03-15 |
2014-09-18 |
Pearl Therapeutics, Inc. |
Methods and systems for conditioning of particulate crystalline materials
|
GB201306984D0
(en)
|
2013-04-17 |
2013-05-29 |
Mexichem Amanco Holding Sa |
Composition
|
US9102633B2
(en)
|
2013-12-13 |
2015-08-11 |
Parion Sciences, Inc. |
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
|
MX368835B
(es)
|
2013-12-30 |
2019-10-18 |
Chiesi Farm Spa |
Composición combinada de bromuro de glicopirronio y formoterol en solución estable presurizada para aerosol.
|
WO2015120392A1
(en)
|
2014-02-10 |
2015-08-13 |
Patara Pharma, LLC |
Mast cell stabilizers for lung disease treatment
|
DK3104853T3
(da)
|
2014-02-10 |
2019-12-09 |
Respivant Sciences Gmbh |
Behandling med mastcellestabilisatorer til systemiske forstyrrelser
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
WO2017027387A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
EP3383366B2
(en)
|
2015-12-04 |
2024-06-05 |
Mexichem Fluor S.A. de C.V. |
Pharmaceutical composition
|
AU2017321495A1
(en)
|
2016-08-31 |
2019-03-21 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
CN114272238A
(zh)
|
2016-09-19 |
2022-04-05 |
墨西哥氟石股份公司 |
药物组合物
|
BR112019005168A2
(pt)
|
2016-09-19 |
2019-06-11 |
Mexichem Fluor Sa De Cv |
composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica
|
AU2017328905C1
(en)
|
2016-09-19 |
2020-08-06 |
Mexichem Fluor S.A. De C.V. |
Pharmaceutical composition
|
CN109803724A
(zh)
|
2016-10-07 |
2019-05-24 |
瑞思皮万特科学有限责任公司 |
用于治疗肺纤维化的色甘酸组合物
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|
EA201990605A1
(ru)
*
|
2016-10-14 |
2019-10-31 |
|
Распыляемые композиции тиотропия и формотерола
|
WO2020031148A1
(en)
*
|
2018-08-10 |
2020-02-13 |
Tykhonivska Nataliya |
Pharmaceutical composition, medicinal product and method of treatment of bronchopulmonary obstructive diseases
|
CN112972384B
(zh)
*
|
2019-12-02 |
2022-03-18 |
长风药业股份有限公司 |
一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法
|
AU2019477296A1
(en)
|
2019-12-02 |
2022-04-14 |
Chiesi Farmaceutici S.P.A. |
Stainles steel can for pressurised metered dose inhalers
|
WO2023227781A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|
WO2023227783A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|
WO2023227782A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|